Tuberculosis Treatment Outcomes and Associated Factors in Benadir Somalia. A Multicenter Cohort Study
DOI: https://doi.org/10.2147/ijgm.s463237
IF: 2.145
2024-06-12
International Journal of General Medicine
Abstract:Mevlüt Karata&scedil, Abdirahman Mohamed Hassan Dirie, Sedat Çolako&gbrevelu, Abdirahman Osman Hussein, Amal Nor Ali Pulmonology Department, Somalia Mogadishu Türkiye Recep Tayyip Erdo&gbrevean Training and Research Hospital, Mogadishu, Benadir, Somalia Correspondence: Mevlüt Karataş Abdirahman Mohamed Hassan Dirie, Email ; Background: In low-resource countries like Somalia, tuberculosis (TB) is still a serious global health concern. Understanding the treatment outcomes of TB patients in specific regions is crucial for developing effective strategies to combat the disease. This study aimed to assess the treatment outcomes of TB patients in Benadir, Somalia. Methods: A retrospective cohort study was conducted using data from TB treatment centers in Benadir, Somalia. The study included all TB patients who initiated treatment between July 1, 2019 and June 30, 2020. Treatment outcomes, including treatment success, treatment failure, lost, death, and transfer out, were analyzed. Factors associated with treatment outcomes were also examined using chi-square test. Results: The study comprised 3165 TB patients in total. The mean age of the observations was 29.9 years, with males making up the majority (64.58%). The overall success rate of TB treatment was 80.6%, with 5.3% lost, 4.6% died, 0.5% failed, 4.6% transferred out, and 4.4% not evaluated. Factors associated with unfavorable treatment outcomes included older age and HIV co-infection. Conclusion: The treatment success rate for TB patients in Benadir, Somalia, is below the global target of 90%. Enhancing access to quality TB diagnostic and treatment services, as well as addressing social and economic barriers to treatment adherence, are essential for improving TB control in Benadir, Somalia. Keywords: TB, treatment failure, treatment success, outcomes Tuberculosis (TB) is an infectious disease, one of the world's most common causes of death, and significantly contributes to poor health. TB was the most common cause of death from a single infectious disease prior to the COVID-19 pandemic. 1,2 No matter their age, gender, or race, TB can afflict anyone. Approximately 90% of all cases of tuberculosis (TB) occur in adults, with a higher incidence rate in males than in women. 1 Adult males account for 56% of all cases of TB, whereas adult females account for 33% and children for 11%. 3,4 The World Health Organization (WHO) estimates that Mycobacterium tuberculosis (MTB), the TB causative organism, infects one-third of the world's population, or roughly two billion individuals. 5 TB determinants like poverty, malnutrition, HIV infection, smoking, and diabetes can have an impact on the number of people who contract infection and treatment outcomes. 1 A number of studies have found that age, biological sex, comorbidity or underlying health issues, pretreatment weight, financial circumstances, and family support are all factors impacting TB treatment results in Sub-Saharan Africa. 6 Between 2019 and 2021, the estimated number of TB deaths increased globally, reversing years of decline between 2005 and 2019. 1 According to estimates, 1.4 million HIV-negative people and187000HIV-positive people died in 2021 due to TB co-infection. 1 Due to the resurgence of TB, the Stop TB Strategy implemented the standardized directly observed treatment (DOTS) in 1993 in order to scale up TB prevention and control. 7 The number of TB cases worldwide in 2019 was estimated to be 10.0 million (range, 8.9–11.0 million), a figure that has been steadily declining in recent years. 3,8 China and India are responsible for more than half of the global TB burden. The countries in Sub-Saharan Africa have the highest rates of TB infection worldwide. 9 Drug-resistant TB (DR-TB) is still a threat to the public's health. Resistance to rifampicin, the most effective first-line treatment, is the main cause for concern. The prevalence of multi-drug-resistant TB was reported as being 10.56% in Somalia. 4 Globally, eighty-six percent of those started on first-line TB treatment in 2020 had a successful treatment outcome, but rates remain lower among people living with HIV. 1 The prevalence of HIV among the Somali population is not known, but the prevalence of HIV among TB cases in Somalia was reported to be very low, reaching 1.5%. 10 Usually, immunocompetent patients with tuberculosis (TB) exhibit typical symptoms, but in very rare situations, atypical TB symptoms could show up as active pulmonary tuberculosis with empyema necessitans in patients who are immune-competent. 11 In the civil war era, the health system of the Benadir region and other feder -Abstract Truncated-
medicine, general & internal